Ophthalmology Doctors in Houma, LA Accepting Medicare

7 Ophthalmology doctors found. Showing 1 - 7

Dr. Van Michael Ardoin, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 603 Dunn St, Houma, LA 70360 Phone: 985-876-6980    Fax: 985-876-6975

Dr. Keith Emery Kellum, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 446 Corporate Drive, Houma, LA 70360 Phone: 985-872-5577    Fax: 985-868-4190

Dr. Robert A Gordon, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 446 Corporate Dr, Houma, LA 70360 Phone: 985-872-5577    Fax: 985-868-4190

Dr. Seema Gauri Walia, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 249 Corporate Dr, Houma, LA 70360 Phone: 985-853-0900

Abram D Tipton Iv, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1990 Industrial Boulevard, Houma, LA 70363 Phone: 985-868-9300    Fax: 985-851-0053

Dr. Aravinda Kurella Rao, M.D. Ophthalmology - Retina Specialist Medicare: Accepting Medicare Assignments Practice Location: 444a Paddock Ln, Houma, LA 70360 Phone: 985-333-4090

Dr. Arthur Joseph Delahoussaye, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 249 Corporate Dr, Houma, LA 70360 Phone: 985-853-0900    Fax: 985-853-0903

News Archive

Mortality risk after heart bypass surgery four times higher in patients with high body fat mass

New research presented at this year's Euroanaesthesia congress in Vienna, Austria (1-3 June) shows that mortality in patients who had undergone heart bypass surgery was over 4 times higher in individuals with a high body fat mass, while body mass index (BMI) by itself was not associated with an increase in mortality.

e-Therapeutics' ETS2101 cancer trials on track

e-Therapeutics plc today provides an update on the clinical trials of its cancer drug ETS2101. Two phase I studies, one in patients with primary or secondary brain cancer and the other in patients with various solid tumours, remain on track to report final data in Q4 2013 and Q1 2014, respectively. Interim data from the trials are expected in H1 2013.

American Diabetes Association lauds Senate for passage of Stem Cell Research Enhancement Act

The American Diabetes Association today issued the following statement in response to the passage by the Senate of the "Stem Cell Research Enhancement Act" (S.5), which will accelerate stem cell research by easing existing funding restrictions and supporting research that uses embryonic stem cells, while maintaining strict ethical guidelines.

Weekend reading: Chemo revolution, Lyme disease confusion and the residency mismatch

Because I've lived so long with anxiety, there were lots of things I figured I'd never, ever do -; having children was one of them. In fact, in my 20s, before I'd managed to stumble on the combination of drugs and exercise that allows me to be as sane as I can expect to be, I was so sure I'd never give birth that I got a tattoo of a giant koi fish extending from one end of my abdomen to the other. ... I found myself in a very ironic situation: my decision to have a child was the result of a sense of stability I enjoyed due to taking an array of anti-anxiety medications that I would be strongly advised by most doctors to stop taking now that I was pregnant (Alissa Nutting, 6/23).

Read more Medical News

› Verified 3 days ago